0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases

Not currently available

A National Strategy for the Elimination of Hepatitis B and C - Phase Two Report (Paperback) Loot Price: R1,634
Discovery Miles 16 340
A National Strategy for the Elimination of Hepatitis B and C - Phase Two Report (Paperback): National Academies of Sciences,...

A National Strategy for the Elimination of Hepatitis B and C - Phase Two Report (Paperback)

National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on a National Strategy for the Elimination of Hepatitis B and C; Edited by Brian L. Strom, Gillian J. Buckley

 (sign in to rate)
Loot Price R1,634 Discovery Miles 16 340 | Repayment Terms: R153 pm x 12*

Bookmark and Share

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them. Table of Contents Front Matter Summary 1 Introduction 2 Targets for Elimination 3 Public Health Information 4 Essential Interventions 5 Service Delivery 6 Financing Elimination 7 Research Appendix A: Population Health Impact and Cost-Effectiveness of Chronic Hepatitis B Diagnosis, Care, and Treatment in the United States Appendix B: Modeling the Elimination of Hepatitis C in the United States Appendix C: Public Meeting Agenda Appendix D: Committee Biographies

General

Imprint: National Academies Press
Country of origin: United States
Release date: July 2017
First published: 2017
Authors: National Academies of Sciences, Engineering, and Medicine • Health and Medicine Division • Board on Population Health and Public Health Practice • Committee on a National Strategy for the Elimination of Hepatitis B and C
Editors: Brian L. Strom • Gillian J. Buckley
Dimensions: 229 x 152mm (L x W)
Format: Paperback
Pages: 296
ISBN-13: 978-0-309-45729-3
Categories: Books > Medicine > General issues > Public health & preventive medicine > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases > General
LSN: 0-309-45729-7
Barcode: 9780309457293

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners